Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Company Profile and bullboard matches:

SRPIF
Sort by: Date|Relevance

FDA Grants Ampio Pharma Approval to Begin Phase 1 Trial in COVID-19 Patients

Ampio Pharmaceuticals' shares traded higher after the company reported that the FDA cleared the firm to proceed with human trials of its Investigative New Drug application for intravenous AmpionTM for treatment in COVID-19 affected patients on supplemental oxygen. ...
Streetwise Reports | June 22, 2020 |

Permex Petroleum: A uniquely positioned junior oil & gas company

The world of oil and gas has been fascinating to watch recently as issues with the global supply chain and ongoing war with Russia and Ukraine have seen prices hit decades-long highs, leading the U.S. government to tap into its strategic reserves and URGE domestic produce...
Daniella Atkinson | October 24, 2022 |

BioNTech, CureVac, Valeo Pharma - COVID-19 wakes up the industry

In the past, people have accepted that it usually takes about ten years to get a vaccine on the market. Careful testing with proof of success is required for a preparation to receive approvals. Since COVID-19, the pressure to develop has increased dramatically and also the pot...
Mario Hose | September 1, 2020 |

Buzz on the Bullboards: When will the bear awaken?

2023 has started off with a bang for investors, as many sectors continue to adjust to rising inflation. It has been an up-and-down week for Canadian markets so far, but there seems to be an upbeat sentiment from markets across the globe. Many expect the Federal Reserv...
Jonathon Brown | January 12, 2023 |

The Fed Meets the S&P 500 Bull

Yesterday's Fed statement drove stock lower, but did the overnight slide tick all the boxes so far – that's the question to ask. And why exactly did the market get so disappointed with the FOMC moves? I'll answer these questions in today's analysis, and lay out the prospects f...
Monica Kingsley | June 11, 2020 |

Cobaltech (CSK.V) crushes the market, jumps 44% as Cobalt, Ontario heats up

“Your share price is down a little,” I said a few days ago to Bruce Bragagnolo, Chairman of Cobaltech Mining (CSK.V). “What gives?” “Well, we did have an issue,” he replied. “We announced an LOI to purchase ...
Chris Parry | May 2, 2017 |

Warning – That’s Not a Buying Opportunity in Gold

Gold rallied by $17.20 yesterday (1.08%), while silver soared by $0.42 (2.35%), which means that silver more than doubled gold’s rally. Silver is outperforming gold, which was both profitable, and informative. Gold miners moved higher even more (4.60% in case o...
Przemyslaw Radomski, CFA | February 19, 2020 |

Navidea Shares Jump 60% on Phase 2b Rheumatoid Arthritis Trial Results

Shares of Navidea Biopharmaceuticals traded 60% higher today on extremely high relative volume after the firm released data from its Phase 2b Rheumatoid Arthritis Tc 99m Tilmanocept Planar Imaging study. Developer of precision immunodiagnostic agents and immunotherape...
Streetwise Reports | October 30, 2019 |

Apache and Total Form $5 Billion Joint Venture to Drill off Suriname Coast

Shares of Apache Corp. traded 16% higher today after the company reported that it has formed a joint venture with Total SA of France to explore and develop Block 58 offshore Suriname. Late yesterday evening, oil and gas exploration and production company Apache Corp....
Streetwise Reports | December 27, 2019 |

Top Two ETF Trends to Watch: ESG and Nontransparent

U.S.-based ETFs had a red-hot 2019, ending the year with $4.4 trillion in assets, a 30 percent increase from 2018. Even bigger changes could be headed our way, if some of the discussions at this year’s Inside ETFs are any indication. Two topics seemed ...
Frank Holmes | February 3, 2020 |
1 2 3 4 5 6 7